PriceTargets.com logo

Lemonade - LMND Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $58.57
  • Forecasted Upside: -23.59%
  • Number of Analysts: 8
  • Breakdown:
  • 4 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 1 Strong Buy Ratings
$76.66 As of 12/4/2025 04:59 PM ET
▲ +3.065 (4.16%)

This chart shows the closing price for LMND by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Lemonade Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LMND and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LMND

Analyst Price Target is $58.57
▼ -23.59% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Lemonade in the last 3 months. The average price target is $58.57, with a high forecast of $80.00 and a low forecast of $40.00. The average price target represents a -23.59% upside from the last price of $76.66.

This chart shows the closing price for LMND for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 8 polled investment analysts is to hold stock in Lemonade. This rating changed within the last month from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 3 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
6/8/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
9/6/2025
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
11/5/2025
  • 1 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 1 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 4 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2025Keefe, Bruyette & WoodsBoost TargetUnderperform ➝ Underperform$35.00 ➝ $40.00
11/24/2025JMP SecuritiesSet Target$80.00
11/24/2025CitigroupReiterated RatingMarket Outperform ➝ Market Outperform
11/24/2025Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$60.00 ➝ $80.00
11/17/2025Morgan StanleyBoost TargetUnderweight ➝ Underweight$49.00 ➝ $53.00
11/10/2025Morgan StanleyBoost TargetUnderweight ➝ Underweight$45.00 ➝ $49.00
10/10/2025Piper SandlerLower TargetNeutral ➝ Neutral$60.00 ➝ $55.00
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
10/7/2025Morgan StanleyBoost TargetUnderweight ➝ Underweight$43.00 ➝ $45.00
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/17/2025Piper SandlerBoost TargetNeutral ➝ Neutral$55.00 ➝ $60.00
8/18/2025Morgan StanleyReiterated RatingUnderweight ➝ Underweight
8/18/2025BMO Capital MarketsBoost TargetUnderperform ➝ Underperform$23.00 ➝ $42.00
8/14/2025Piper SandlerReiterated RatingNeutral$55.00
8/14/2025Piper SandlerReiterated RatingHold$55.00
8/13/2025Cantor FitzgeraldUpgradeStrong-Buy
8/12/2025Cantor FitzgeraldInitiated CoverageOverweight$60.00
7/14/2025Morgan StanleyReiterated RatingUnderweight ➝ Underweight$24.00 ➝ $26.00
7/2/2025BMO Capital MarketsBoost TargetUnderperform ➝ Underperform$15.00 ➝ $23.00
7/1/2025Keefe, Bruyette & WoodsReiterated RatingUnderperform ➝ Underperform$22.00 ➝ $26.00
4/22/2025Keefe, Bruyette & WoodsLower TargetUnderperform ➝ Underperform$25.00 ➝ $22.00
4/8/2025Morgan StanleyDowngradeEqual Weight ➝ Underweight$35.00 ➝ $24.00
2/26/2025Piper SandlerLower TargetNeutral ➝ Neutral$44.00 ➝ $34.00
11/22/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$40.00 ➝ $60.00
11/21/2024BMO Capital MarketsBoost TargetUnderperform ➝ Underperform$13.00 ➝ $15.00
11/21/2024Piper SandlerBoost TargetNeutral ➝ Neutral$25.00 ➝ $44.00
11/20/2024Morgan StanleyUpgradeUnderweight ➝ Equal Weight$23.00 ➝ $42.00
11/15/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$15.00 ➝ $23.00
11/7/2024Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$18.00 ➝ $21.00
11/1/2024Piper SandlerBoost TargetNeutral ➝ Neutral$18.00 ➝ $25.00
10/15/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$40.00 ➝ $40.00
10/9/2024Jefferies Financial GroupLower TargetUnderperform ➝ Underperform$15.00 ➝ $14.00
5/7/2024Jefferies Financial GroupBoost TargetUnderperform ➝ Underperform$14.00 ➝ $16.00
5/2/2024Piper SandlerBoost TargetNeutral ➝ Neutral$17.00 ➝ $18.00
4/15/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$40.00
3/4/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$16.00 ➝ $18.00
2/29/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$17.00
2/28/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$13.00 ➝ $14.00
1/10/2024TD CowenInitiated CoverageMarket Perform$17.00
12/1/2023OppenheimerReiterated RatingOutperform ➝ Market Perform
11/2/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$10.00 ➝ $11.00
10/11/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$15.00 ➝ $10.00
10/6/2023Jefferies Financial GroupLower Target$14.00 ➝ $10.00
9/28/2023BMO Capital MarketsBoost TargetUnderperform ➝ Underperform$8.00 ➝ $9.00
8/4/2023Piper SandlerLower TargetNeutral ➝ Neutral$18.00 ➝ $17.00
8/3/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$14.00 ➝ $15.00
6/20/2023Morgan StanleyInitiated CoverageUnderweight$14.00
5/9/2023BarclaysBoost Target$16.00 ➝ $17.00
5/4/2023Bank of AmericaLower Target$14.00 ➝ $12.00
4/10/2023Jefferies Financial GroupLower TargetUnderperform$13.00 ➝ $11.50
2/24/2023Piper SandlerLower TargetNeutral$19.00 ➝ $18.00
2/24/2023BarclaysLower TargetEqual Weight$18.00 ➝ $16.00
1/19/2023BMO Capital MarketsInitiated CoverageUnderperform$10.00
1/18/2023Piper SandlerLower TargetNeutral$20.00 ➝ $19.00
11/17/2022Keefe, Bruyette & WoodsInitiated CoverageMarket Perform$24.00
11/15/2022OppenheimerLower Target$30.00
11/10/2022Piper SandlerLower TargetNeutral$25.00 ➝ $20.00
11/10/2022BarclaysLower TargetEqual Weight$28.00 ➝ $18.00
8/10/2022OppenheimerBoost Target$30.00 ➝ $35.00
8/10/2022BarclaysBoost TargetEqual Weight$20.00 ➝ $28.00
8/10/2022Piper SandlerBoost TargetNeutral$20.00 ➝ $25.00
7/22/2022Credit Suisse GroupLower Target$14.00
7/18/2022Piper SandlerDowngradeOverweight ➝ Neutral$24.00 ➝ $20.00
5/11/2022OppenheimerLower Target$45.00 ➝ $30.00
5/11/2022JMP SecuritiesLower Target$95.00 ➝ $40.00
3/4/2022Morgan StanleyLower TargetEqual Weight$74.00 ➝ $28.00
2/25/2022BarclaysLower Target$43.00 ➝ $22.00
2/25/2022OppenheimerLower TargetOutperform$85.00 ➝ $45.00
2/25/2022Piper SandlerLower TargetOverweight$54.00 ➝ $32.00
1/13/2022Piper SandlerLower TargetOverweight$84.00 ➝ $54.00
1/6/2022BarclaysLower TargetEqual Weight$62.00 ➝ $43.00
11/18/2021Jefferies Financial GroupInitiated CoverageUnderperform$49.00
11/10/2021OppenheimerLower TargetOutperform$95.00 ➝ $85.00
11/10/2021JMP SecuritiesLower TargetOutperform$130.00 ➝ $95.00
11/10/2021BarclaysLower TargetEqual Weight$68.00 ➝ $62.00
10/19/2021BarclaysLower TargetEqual Weight$80.00 ➝ $68.00
10/15/2021Morgan StanleyLower TargetEqual Weight$90.00 ➝ $74.00
8/16/2021Wolfe ResearchInitiated CoverageUnderperform$53.00
8/6/2021OppenheimerBoost TargetOutperform$85.00 ➝ $95.00
8/6/2021Piper SandlerLower TargetOverweight$103.00 ➝ $98.00
5/13/2021BarclaysLower TargetEqual Weight$101.00 ➝ $71.00
3/30/2021Piper SandlerLower TargetOverweight$159.00 ➝ $134.00
3/9/2021Bank of AmericaInitiated CoverageUnderperform$29.00
3/8/2021OppenheimerUpgradeMarket Perform ➝ Outperform$110.00
3/3/2021JMP SecuritiesBoost TargetOutperform$105.00 ➝ $130.00
1/21/2021Piper SandlerBoost TargetOverweight$105.00 ➝ $163.00
1/12/2021Morgan StanleyBoost TargetEqual Weight$70.00 ➝ $90.00
12/16/2020Piper SandlerBoost TargetOverweight$71.00 ➝ $105.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

1.16 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 6 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 10 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 10 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 10 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Lemonade logo
Lemonade, Inc. provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, car, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Read More

Today's Range

Now: $76.66
Low: $72.16
High: $78.76

50 Day Range

MA: $62.63
Low: $47.63
High: $79.18

52 Week Range

Now: $76.66
Low: $24.31
High: $83.77

Volume

2,085,425 shs

Average Volume

2,635,920 shs

Market Capitalization

$5.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.13

Frequently Asked Questions

What sell-side analysts currently cover shares of Lemonade?

The following Wall Street sell-side analysts have issued stock ratings on Lemonade in the last twelve months: BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Citizens Jmp, JMP Securities, Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for LMND.

What is the current price target for Lemonade?

0 Wall Street analysts have set twelve-month price targets for Lemonade in the last year. Their average twelve-month price target is $58.57, suggesting a possible downside of 23.6%. JMP Securities has the highest price target set, predicting LMND will reach $80.00 in the next twelve months. Keefe, Bruyette & Woods has the lowest price target set, forecasting a price of $40.00 for Lemonade in the next year.
View the latest price targets for LMND.

What is the current consensus analyst rating for Lemonade?

Lemonade currently has 4 sell ratings, 1 hold rating, 2 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in LMND, but not buy more shares or sell existing shares.
View the latest ratings for LMND.

What other companies compete with Lemonade?

Other companies that are similar to Lemonade include Upstart, Allstate, Progressive, Principal Financial Group and Brookfield Wealth Solutions. Learn More about companies similar to Lemonade.

How do I contact Lemonade's investor relations team?

Lemonade's physical mailing address is 5 CROSBY STREET 3RD FLOOR, NEW YORK NY, 10013. The company's listed phone number is 844-733-8666 and its investor relations email address is [email protected]. The official website for Lemonade is www.lemonade.com. Learn More about contacing Lemonade investor relations.